What Is Histone Lactylation and Why Does It Matter?
The Short Answer
Histone lactylation is the addition of a lactyl group to lysine residues on histones, derived from lactate. It was reported in 2019 as a modification that accumulates in response to lactate and that correlates with transcriptional activation of specific genes.
Why it matters: it is one of the clearest proposed mechanisms linking cell metabolism to chromatin state, relevant to tumours (high lactate), immune activation, and ischaemic or hypoxic tissue. Why it needs care: the writers, erasers, and functional consequences are still being established, and the field has a habit of asserting mechanism from correlation.
Part 1 — The Chemistry, Briefly
- • Source. Lactate, abundant in glycolytic states, is converted to lactyl-CoA, which can be used for lysine lactylation.
- • Marks. Reported at several lysine residues on H3 and H4 (e.g., H3K18la, H3K9la), with H3K18la the most studied.
- • Mass. A lactyl group adds 72 Da, which is isobaric with some other modifications — a mass-spectrometry complication that makes antibody-independent confirmation important.
- • Crosstalk. Lactylation competes with acetylation at the same lysines, which is mechanistically attractive: a metabolic signal directly competing with a chromatin-activation mark.
The competition with acetylation is the most biologically interesting part, because it suggests a mechanism by which metabolic state could tune, rather than simply switch, transcription.
Part 2 — Writers and Erasers: An Evolving Picture
| Component | Reported role | Status |
|---|---|---|
| p300/CBP | Lactyltransferase activity in vitro and in cells | Widely cited; relative efficiency versus acetylation debated |
| AARS1/AARS2 | Lactate-sensing and lactyl-transfer activity in some reports | Recent; independent replication still accumulating |
| HDAC1–3 | Delactylase activity | Reported; class specificity and substrate preference still being defined |
| SIRT1–3 | Delactylase activity in some contexts | Reported; context-dependent |
Two cautions for anyone designing experiments: the enzyme list is not settled, and many assignments rest on overexpression or inhibitor studies rather than on genetic loss-of-function with mark-level readout.
Part 3 — What the Functional Evidence Supports
Defensible statements at present:
- • Lactylation marks increase when cells are exposed to lactate or shifted toward glycolysis, in multiple cell types.
- • Certain loci show increased H3K18la and increased transcription under those conditions, notably in macrophage activation and in tumour models.
- • Genetic or pharmacological reduction of the putative writers reduces both the mark and the associated transcriptional response in some systems.
Statements that outrun the evidence:
- • "Lactylation is the mechanism of the Warburg effect." The correlation with glycolytic flux is strong; the causal chain is not established.
- • "Lactylation directly activates gene X." Promoter-specific deposition with a targeted editor, plus a functional readout, would be needed; antibody-based ChIP evidence is a start, not a conclusion.
- • "Lactylation is a general activation mark." Its genomic distribution and relationship to acetylation vary between studies.
Part 4 — Why the Field Is Growing Quickly
Three reasons, in order of importance:
- It connects two fields that were previously separate. Metabolism and chromatin had few direct mechanistic links; lactylation offers one that is chemically plausible and experimentally accessible.
- The tumour relevance is obvious. High lactate is a feature of many tumours, and a mark that responds to lactate suggests a route by which the metabolic environment reprograms transcription.
- The tools are cheap. Lactate treatment, glycolysis modulation, and antibody-based detection are accessible to most labs — which also explains the volume of correlative papers.
Part 5 — Designing a Study That Holds Up
If you are entering this area, four design choices separate a solid contribution from another correlation:
- • Confirm the mark with mass spectrometry, not antibody alone, at least in one system.
- • Test the writer genetically (knockout or degron), not only with inhibitors; report the effect on both the mark and the transcript.
- • Separate lactate's metabolic effects from its chromatin effects. Lactate alters pH, redox, and metabolism broadly; a control in which lactate is supplied but the mark cannot be deposited is the informative comparison.
- • Use a targeted perturbation if claiming locus specificity: recruitment of a putative lactyltransferase to an element, with a catalytically dead control.
Part 6 — Where It Fits in This Series
Lactylation is a case study in the general problem this cluster addresses: a modification is discovered, correlated with a transcriptional state, and then assigned a mechanism before the causal tools have been applied. The validation logic in our pillar — mark-level evidence, specificity, catalytically dead controls, functional readout — applies here without modification.
Need mark-level validation in a controlled system?
EDITGENE builds cell models for metabolic-epigenetic work: isogenic lines with defined glycolytic states, knockout and degron lines for candidate writers, and reporter systems for locus-level readouts.
Tell us the mark and the model system you need. Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
The enzymology of lactylation is under active revision; assignments of writers and erasers cited here reflect the current literature and may change.
Correlations between lactate exposure, mark abundance, and transcription do not establish mechanism. Causal claims require genetic perturbation of the machinery and locus-level functional readouts.
Selected references for further reading
- • Zhang D, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575–580.
- • Moreno-Yruela C, et al. Class I histone deacetylases (HDAC1–3) are histone lysine delactylases. Science Advances. 2022;8:eabi6696.
- • Zessin M, et al. Uncovering robust delactoylase and depyruvoylase activities of HDAC isoforms. ACS Chemical Biology. 2022;17:1359–1369.
- • Li H, et al. Lactate metabolism and histone lactylation in cancer. Molecular Cancer. 2024;23:1–18.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »